NADPH- and iron-dependent lipid peroxidation inhibit aromatase activity in human placental microsomes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 110, Issue 3-5, 2008, Pages 230-235

  Milczarek, Ryszard ^a   Sokołowska, Ewa ^a   Hallmann, Anna ^a   Kaletha, Krystian ^a   Klimek, Jerzy ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Aromatase; Cytochrome P450; Free radicals; Iron; Lipid peroxidation; Microsomes; Placenta; Pre eclampsia; Pregnancy

Indexed keywords

ALPHA TOCOPHEROL; AROMATASE; CATALASE; CYTOCHROME P450; EDETIC ACID; FERROUS CHLORIDE; HYDROXYL RADICAL; MAGNESIUM CHLORIDE; MANNITOL; PLACENTA ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MICROSOME; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN DEGRADATION;

AROMATASE; AROMATASE INHIBITORS; ENZYME ACTIVATION; FEMALE; HUMANS; IRON; LIPID PEROXIDATION; MICROSOMES; NADP; PLACENTA; PREGNANCY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 44949117410     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.11.004     Document Type: Article

References (44)

1. Walsh S.W., Wang Y., and Jesse R. Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia, Hypertens. Pregnancy 15 (1996) 101-111
2. Sikkema J.M., van Rijn B.B., Franx A., Bruinse H.W., de Roos R., Stroes E.S., and van Faassen E.E. Placental superoxide is increased in pre-eclampsia. Placenta 22 (2001) 304-308
3. Klimek J. The involvement of superoxide and iron ions in the NADPH-dependent lipid peroxidation in human placental mitochondria. Biochim. Biophys. Acta 958 (1988) 31-39
4. Klimek J. Cytochrome P-450 involvement in the NADPH-dependent lipid peroxidation in human placental mitochondria. Biochim. Biophys. Acta 1044 (1990) 158-164
5. Klimek J., Wozniak M., Szymanska G., and Zelewski L. Inhibitory effect of free radicals derived from organic hydroperoxide on progesterone synthesis in human term placental mitochondria. Free Radic. Biol. Med. 24 (1998) 1168-1175
6. Klimek J. The influence of NADPH-dependent lipid peroxidation on the progesterone biosynthesis in human placental mitochondria. J. Steroid Biochem. Mol. Biol. 42 (1992) 729-736
7. Milczarek R., Klimek J., and Zelewski L. The effects of ascorbate and α-tocopherol on the NADPH-dependent lipid peroxidation in human placental mitochondria. Mol. Cell Biochem. 210 (2000) 65-73
8. Wang Y., and Walsh S.W. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 19 (1998) 581-586
9. Cui X.L., Brockman D., Campos B., and Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27 (2006) 422-431
10. Milczarek R., Sokolowska E., Hallmann A., and Klimek J. The NADPH- and iron-dependent lipid peroxidation in human placental microsomes. Mol. Cell Biochem. 295 (2007) 105-111
11. Walsh S.W., and Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J. Clin. Endocrinol. Metab. 80 (1995) 1888-1893
12. Hakkola J., Pelkonen O., Pasanen M., and Raunio H. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit. Rev. Toxicol. 28 (1998) 35-72
13. Serin I.S., Kula M., Basbug M., Unluhizarci K., Gucer S., and Tayyar M. Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery. Acta Obstet. Gynecol. Scand. 80 (2001) 1009-1013
14. Salamalekis E., Bakas P., Vitoratos N., Eleptheriadis M., and Creatsas G. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 126 (2006) 16-19
15. Troisi R., Potischman N., Roberts J.M., Ness R., Crombleholme W., Lykins D., Siiteri P., and Hoover R.N. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int. J. Epidemiol. 32 (2003) 455-460
16. Hahnel M.E., Martin J.D., Michael C.A., and Hahnel R. Metabolism of androstenedione by placental microsomes in pregnancy hypertension. Clin. Chim. Acta 181 (1989) 103-108
17. Grumbach M.M., and Auchus R.J. Estrogen: consequences and implications of human mutations in synthesis and action. J. Clin. Endocrinol. Metab. 84 (1999) 4677-4694
18. Albrecht E.D., Aberdeen G.W., and Pepe G.J. The role of estrogen in the maintenance of primate pregnancy. Am. J. Obstet. Gynecol. 182 (2000) 432-438
19. Acromite M.T., Mantzoros C.S., Leach R.E., Hurwitz J., and Dorey L.G. Androgens in preeclampsia. Am. J. Obstet. Gynecol. 180 (1999) 60-63
20. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
21. Shimizu Y., Yarborough C.P., Elger W., Chwalisz K., and Osawa Y. Inhibition of aromatase activity in human placental microsomes by 13-retro-antiprogestins. Steroids 60 (1995) 234-238
22. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes II. Solubilization, purification, and properties. J. Biol. Chem. 239 (1964) 2379-2385
23. Brogan W.C., Miles P.R., and Colby H.D. Effects of lipid peroxidation on adrenal microsomal monooxygenases. Biochim. Biophys. Acta 758 (1983) 114-120
24. 2+-induced lipid peroxidation upon microsomal steroidogenic enzyme activities of porcine adrenal cortex. Biochem. Biophys. Res. Commun. 128 (1985) 657-663
25. Iba M.M., and Mannering G.J. NADPH- and linoleic acid hydroperoxide-induced lipid peroxidation and destruction of cytochrome P-450 in hepatic microsomes. Biochem. Pharmacol. 36 (1987) 1447-1455
26. Klimek J., Schaap A.P., and Kimura T. The relationship between NADPH-dependent lipid peroxidation and degradation of cytochrome P-450 in adrenal cortex mitochondria. Biochem. Biophys. Res. Commun. 110 (1983) 559-566
27. Korsmeyer K.K., Davoll S., Figueiredo-Pereira M.E., and Correia M.A. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome?. Arch. Biochem. Biophys. 365 (1999) 31-44
28. Thompson Jr. E.A., and Siiteri P.K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J. Biol. Chem. 249 (1974) 5373-5378
29. Puntarulo S., and Cederbaum A.I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radic. Biol. Med. 24 (1998) 1324-1330
30. Karuzina I.I., Zgoda V.G., Kuznetsova G.P., Samenkova N.F., and Archakov A.I. Heme and apoprotein modification of cytochrome P450 2B4 during its oxidative inactivation in monooxygenase reconstituted system. Free Radic. Biol. Med. 26 (1999) 620-632
31. He K., Bornheim L.M., Falick A.M., Maltby D., Yin H., and Correia M.A. Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4. Biochemistry 37 (1998) 17448-17457
32. Yao K., Falick A.M., Patel N., and Correia M.A. Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide. J. Biol. Chem. 268 (1993) 59-65
33. Amarneh B., and Simpson E.R. Expression of a recombinant derivative of human aromatase P450 in insect cells utilizing the baculovirus vector system. Mol. Cell Endocrinol. 109 (1995) R1-R5
34. Zhang F., Zhou D., Kao Y.C., Ye J., and Chen S. Expression and purification of a recombinant form of human aromatase from Escherichia coli. Biochem. Pharmacol. 64 (2002) 1317-1324
35. Diamant Y.Z., Rimon E., and Evron S. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 14 (1982) 199-204
36. Pepe G.J., and Albrecht E.D. Regulation of functional differentiation of the placental villous syncytiotrophoblast by estrogen during primate pregnancy. Steroids 64 (1999) 624-627
37. Albrecht E.D., Robb V.A., and Pepe G.J. Regulation of placental vascular endothelial growth/permeability factor expression and angiogenesis by estrogen during early baboon pregnancy. J. Clin. Endocrinol. Metab. 89 (2004) 5803-5809
38. Albrecht E.D., Babischkin J.S., Lidor Y., Anderson L.D., Udoff L.C., and Pepe G.J. Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum. Reprod. 18 (2003) 2039-2047
39. Ruiz-Larrea M.B., Martin C., Martinez R., Navarro R., Lacort M., and Miller N.J. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem. Phys. Lipids 105 (2000) 179-188
40. Reyes M.R., Sifuentes-Alvarez A., and Lazalde B. Estrogens are potentially the only steroids with an antioxidant role in pregnancy: in vitro evidence. Acta Obstet. Gynecol. Scand. 85 (2006) 1090-1093
41. Reyes-Romero M.A. The physiological role of estriol during human fetal development is to act as antioxidant at lipophilic milieus of the central nervous system. Med. Hypotheses 56 (2001) 107-109
42. Salas S.P., Marshall G., Gutierrez B.L., and Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47 (2006) 203-208
43. Wassmann K., Wassmann S., and Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ. Res. 97 (2005) 1046-1054
44. Wang Y., and Walsh S.W. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta 22 (2001) 206-212